Overview

To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea

Status:
Active, not recruiting

Trial end date:
2023-06-10

Target enrollment:

Participant gender:

Summary

The goal of this clinical trial is to compare the efficacy of four different drugs in combination for management of irritable bowel syndrome (IBS)-associated diarrhea. The main question to answer is: - Is there a significant difference in effect of different drug combinations in management of irritable bowel syndrome with diarrhea? Participants will be divided into 3 treatment groups. - Each group will be given a combination of drugs for 2 weeks - At the end of study, efficacy of different drug combinations and their potential side effects will be compared between the treatment groups

Phase:

Phase 4

Details

Lead Sponsor:

Bahria University

Treatments:

Alverine
Amitriptyline
Calcium polycarbophil
Mebeverine
Psyllium
Rifaximin